{
  "N/R/U": null,
  "Applicant": "AstraZeneca AB",
  "BLA Number": "761224",
  "Proprietary Name": "Tezspire",
  "Proper Name": "tezepelumab-ekko",
  "BLA Type": "351(a)",
  "Strength": "210MG/1.91ML (110MG/ML)",
  "Dosage Form": "Injection ",
  "Route of Administration": "Subcutaneous",
  "Product Presentation": "Autoinjector",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "1-Feb-23",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": "1",
  "Submission Type": "Supplement",
  "License Number": "2059",
  "Product Number": "3",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": null
}